204 related articles for article (PubMed ID: 25435348)
1. Targeting microglia for the treatment of Alzheimer's disease.
McGeer PL; McGeer EG
Expert Opin Ther Targets; 2015 Apr; 19(4):497-506. PubMed ID: 25435348
[TBL] [Abstract][Full Text] [Related]
2. Temporal changes of CD68 and α7 nicotinic acetylcholine receptor expression in microglia in Alzheimer's disease-like mouse models.
Matsumura A; Suzuki S; Iwahara N; Hisahara S; Kawamata J; Suzuki H; Yamauchi A; Takata K; Kitamura Y; Shimohama S
J Alzheimers Dis; 2015; 44(2):409-23. PubMed ID: 25352454
[TBL] [Abstract][Full Text] [Related]
3. Inflammation, Antiinflammatory Agents, and Alzheimer's Disease: The Last 22 Years.
McGeer PL; Rogers J; McGeer EG
J Alzheimers Dis; 2016 Oct; 54(3):853-857. PubMed ID: 27716676
[TBL] [Abstract][Full Text] [Related]
4. The Multi-Target Drug M30 Shows Pro-Cognitive and Anti-Inflammatory Effects in a Rat Model of Alzheimer's Disease.
Pimentel LS; Allard S; Do Carmo S; Weinreb O; Danik M; Hanzel CE; Youdim MB; Cuello AC
J Alzheimers Dis; 2015; 47(2):373-83. PubMed ID: 26401560
[TBL] [Abstract][Full Text] [Related]
5. Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer's disease.
Cai Z; Hussain MD; Yan LJ
Int J Neurosci; 2014 May; 124(5):307-21. PubMed ID: 23930978
[TBL] [Abstract][Full Text] [Related]
6. Cooperative therapeutic action of retinoic acid receptor and retinoid x receptor agonists in a mouse model of Alzheimer's disease.
Kawahara K; Suenobu M; Ohtsuka H; Kuniyasu A; Sugimoto Y; Nakagomi M; Fukasawa H; Shudo K; Nakayama H
J Alzheimers Dis; 2014; 42(2):587-605. PubMed ID: 24916544
[TBL] [Abstract][Full Text] [Related]
7. Minocycline reduces engraftment and activation of bone marrow-derived cells but sustains their phagocytic activity in a mouse model of Alzheimer's disease.
Malm TM; Magga J; Kuh GF; Vatanen T; Koistinaho M; Koistinaho J
Glia; 2008 Dec; 56(16):1767-79. PubMed ID: 18649403
[TBL] [Abstract][Full Text] [Related]
8. Deglycosylated anti-amyloid beta antibodies reduce microglial phagocytosis and cytokine production while retaining the capacity to induce amyloid beta sequestration.
Takata K; Hirata-Fukae C; Becker AG; Chishiro S; Gray AJ; Nishitomi K; Franz AH; Sakaguchi G; Kato A; Mattson MP; Laferla FM; Aisen PS; Kitamura Y; Matsuoka Y
Eur J Neurosci; 2007 Nov; 26(9):2458-68. PubMed ID: 17970733
[TBL] [Abstract][Full Text] [Related]
9. Minocycline affects microglia activation, Abeta deposition, and behavior in APP-tg mice.
Seabrook TJ; Jiang L; Maier M; Lemere CA
Glia; 2006 May; 53(7):776-82. PubMed ID: 16534778
[TBL] [Abstract][Full Text] [Related]
10. Activated human microglia stimulate neuroblastoma cells to upregulate production of beta amyloid protein and tau: implications for Alzheimer's disease pathogenesis.
Lee M; McGeer E; McGeer PL
Neurobiol Aging; 2015 Jan; 36(1):42-52. PubMed ID: 25169677
[TBL] [Abstract][Full Text] [Related]
11. Alzheimer's disease: microglia targets and their modulation to promote amyloid phagocytosis and mitigate neuroinflammation.
Anwar S; Rivest S
Expert Opin Ther Targets; 2020 Apr; 24(4):331-344. PubMed ID: 32129117
[No Abstract] [Full Text] [Related]
12. Stromal cell-derived factor 1α decreases β-amyloid deposition in Alzheimer's disease mouse model.
Wang Q; Xu Y; Chen JC; Qin YY; Liu M; Liu Y; Xie MJ; Yu ZY; Zhu Z; Wang W
Brain Res; 2012 Jun; 1459():15-26. PubMed ID: 22560596
[TBL] [Abstract][Full Text] [Related]
13. The amyloid cascade-inflammatory hypothesis of Alzheimer disease: implications for therapy.
McGeer PL; McGeer EG
Acta Neuropathol; 2013 Oct; 126(4):479-97. PubMed ID: 24052108
[TBL] [Abstract][Full Text] [Related]
14. TLR2 is a primary receptor for Alzheimer's amyloid β peptide to trigger neuroinflammatory activation.
Liu S; Liu Y; Hao W; Wolf L; Kiliaan AJ; Penke B; Rübe CE; Walter J; Heneka MT; Hartmann T; Menger MD; Fassbender K
J Immunol; 2012 Feb; 188(3):1098-107. PubMed ID: 22198949
[TBL] [Abstract][Full Text] [Related]
15. Tenascin-C deficiency ameliorates Alzheimer's disease-related pathology in mice.
Xie K; Liu Y; Hao W; Walter S; Penke B; Hartmann T; Schachner M; Fassbender K
Neurobiol Aging; 2013 Oct; 34(10):2389-98. PubMed ID: 23673309
[TBL] [Abstract][Full Text] [Related]
16. IFN-γ Production by amyloid β-specific Th1 cells promotes microglial activation and increases plaque burden in a mouse model of Alzheimer's disease.
Browne TC; McQuillan K; McManus RM; O'Reilly JA; Mills KH; Lynch MA
J Immunol; 2013 Mar; 190(5):2241-51. PubMed ID: 23365075
[TBL] [Abstract][Full Text] [Related]
17. Preventive effects of a fermented dairy product against Alzheimer's disease and identification of a novel oleamide with enhanced microglial phagocytosis and anti-inflammatory activity.
Ano Y; Ozawa M; Kutsukake T; Sugiyama S; Uchida K; Yoshida A; Nakayama H
PLoS One; 2015; 10(3):e0118512. PubMed ID: 25760987
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy for Alzheimer's disease.
McGeer PL; McGeer E
Sci Aging Knowledge Environ; 2004 Jul; 2004(27):pe29. PubMed ID: 15243154
[TBL] [Abstract][Full Text] [Related]
19. Locus ceruleus controls Alzheimer's disease pathology by modulating microglial functions through norepinephrine.
Heneka MT; Nadrigny F; Regen T; Martinez-Hernandez A; Dumitrescu-Ozimek L; Terwel D; Jardanhazi-Kurutz D; Walter J; Kirchhoff F; Hanisch UK; Kummer MP
Proc Natl Acad Sci U S A; 2010 Mar; 107(13):6058-63. PubMed ID: 20231476
[TBL] [Abstract][Full Text] [Related]
20. Soluble CCL5 derived from bone marrow-derived mesenchymal stem cells and activated by amyloid β ameliorates Alzheimer's disease in mice by recruiting bone marrow-induced microglia immune responses.
Lee JK; Schuchman EH; Jin HK; Bae JS
Stem Cells; 2012 Jul; 30(7):1544-55. PubMed ID: 22570192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
